首页   按字顺浏览 期刊浏览 卷期浏览 β-Carboline-benzoquinolizidine alkaloid deoxytubulosine inhibits thymidylate synth...
β-Carboline-benzoquinolizidine alkaloid deoxytubulosine inhibits thymidylate synthase activity in leukemic leukocytes from patients with chronic myeloblastic leukemia and acute lymphoblastic leukemia

 

作者: K Narasimha Rao,   RK Bhattacharya,   SR Venkatachalam,  

 

期刊: Anti-Cancer Drugs  (OVID Available online 1998)
卷期: Volume 9, issue 8  

页码: 727-732

 

ISSN:0959-4973

 

年代: 1998

 

出版商: OVID

 

关键词: Acute lymphoblastic leukemia;antitumor compound;chronic myeloblastic leukemia;deoxytubulosine;inhibition;thymidylate synthase

 

数据来源: OVID

 

摘要:

Precursor 2'-deoxythymidine 5'-monophosphate for DNA biosynthesis Is supplied by thymidylate synthase (TS) (EC 2.1.1.45) through a denovopathway and the enzyme levels are elevated in malignancy. TS is therefore a key target for cancer chemotherapy. Human leukocyte TS levels in patients with chronic myeloblastic leukemia (CML) and acute lymphoblastic leukemia (ALL) are highly elevated (66- and 33- fold, respectively) compared to the low baseline activity of normal healthy controls. Preliminary screening tests for the antitumor activity of theβ-carboline-benzoquinolizidine alkaloid deoxytubulosine (DTB) (isolated from the Indian medicinal plantAlanguim lamarcktii) were performed employing Invitroinhibition studies on the leukemic leukocyte TS as the probe enzyme. Enzyme activity of the leukemic leukocytes was potently inhibited by DTB (IC50=50µM) In both CML and ALL. The emetine alkaloid DTB was assessed for its biochemical and biological evaluation for the first time as a potential antileukemic agent.

 

点击下载:  PDF (406KB)



返 回